Epigenetic regulation of cellular adhesion in cancer

Carcinogenesis

Volumn 32, Issue 10, 2011, Pages 1414-1418

  Katto, Judith ^a   Mahlknecht, Ulrich ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; MICRORNA;

CANCER CELL; CARCINOGENESIS; CELL ADHESION; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL INVASION; CELL MOTILITY; DNA METHYLATION; DOWN REGULATION; EMBRYO DEVELOPMENT; EPIGENETICS; GENE EXPRESSION; GENE MUTATION; GENETIC CODE; HISTONE MODIFICATION; HUMAN; METASTASIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN PROCESSING; REVIEW;

ANIMALS; CELL ADHESION; EPIGENESIS, GENETIC; HUMANS; NEOPLASMS;

EID: 80053155728     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr120     Document Type: Review

References (79)

1. Holliday,R. (1987) The inheritance of epigenetic defects. Science, 238, 163-170.
2. Delaval,K. et al. (2004) Epigenetic regulation of mammalian genomic imprinting. Curr. Opin. Genet. Dev., 14, 188-195.
3. Esteller,M. (2002) CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene, 21, 5427-5440.
4. Feinberg,A.P. et al. (2002) DNA methylation and genomic imprinting: insights from cancer into epigenetic mechanisms. Semin. Cancer Biol., 12, 389-398.
5. Lujambio,A. et al. (2007) Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res., 67, 1424-1429.
6. Saito,Y. et al. (2006) Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell, 9, 435-443.
7. Taby,R. et al. (2010) Cancer epigenetics. CA Cancer J. Clin., 60, 376-392.
8. Claus,R. et al. (2003) Epigenetic targets in hematopoietic malignancies. Oncogene, 22, 6489-6496.
9. Mrozek,K. et al. (2007) Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification? Blood, 109, 431-448.
10. Feinberg,A.P. et al. (2004) The history of cancer epigenetics. Nat. Rev. Cancer, 4, 143-153.
11. Sharma,S. et al. (2010) Epigenetics in cancer. Carcinogenesis, 31, 27-36.
12. Esteller,M. (2008) Epigenetics in cancer. N. Engl. J. Med., 358, 1148-1159.
13. Rouhi,A. et al. (2008) MiRNAs, epigenetics, and cancer. Mamm. Genome, 19, 517-525.
14. Turek-Plewa,J. et al. (2005) The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell. Mol. Biol. Lett., 10, 631-647.
15. Nan,X. et al. (1998) Transcriptional repression by the methyl-CpG-binding proteinMeCP2 involves a histone deacetylase complex. Nature, 393, 386-389.
16. Esteller,M. (2005) Aberrant DNA methylation as a cancer-inducing mechanism. Annu. Rev. Pharmacol. Toxicol., 45, 629-656.
17. Bird,A. (2002) DNA methylation patterns and epigenetic memory. Genes Dev., 16, 6-21.
18. Takai,D. et al. (2002) Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc. Natl Acad. Sci. USA, 99, 3740-3745.
19. Wang,Y. et al. (2004) An evaluation of new criteria for CpG islands in the human genome as gene markers. Bioinformatics, 20, 1170-1177.
20. Suzuki,M.M. et al. (2008) DNA methylation landscapes: provocative insights from epigenomics. Nat. Rev. Genet., 9, 465-476.
21. Esteller,M. et al. (2002) Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J. Pathol., 196, 1-7.
22. Bestor,T.H. et al. (1996) Creation of genomic methylation patterns. Nat. Genet., 12, 363-367.
23. Eden,A. et al. (2003) Chromosomal instability and tumors promoted by DNA hypomethylation. Science, 300, 455.
24. Howard,G. et al. (2008) Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice. Oncogene, 27, 404-408.
25. Halkidou,K. et al. (2004) Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer. Prostate, 59, 177-189.
26. Song,J. et al. (2005) Increased expression of histone deacetylase 2 is found in human gastric cancer. APMIS, 113, 264-268.
27. Margueron,R. et al. (2011) The polycomb complex PRC2 and its mark in life. Nature, 469, 343-349.
28. Boyer,L.A. et al. (2006) Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature, 441, 349-353.
29. Kleer,C.G. et al. (2003) EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc. Natl. Acad. Sci. U S A, 100, 11606-11611.
30. Karanikolas,B.D. et al. (2009) Polycomb group protein enhancer of zeste 2 is an oncogene that promotes the neoplastic transformation of a benign prostatic epithelial cell line. Mol. Cancer Res., 7, 1456-1465.
31. Valk-Lingbeek,M.E. et al. (2004) Stem cells and cancer; the polycomb connection. Cell, 118, 409-418.
32. Tachibana,M. et al. (2005) Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. Genes Dev., 19, 815-826.
33. Kondo,Y. et al. (2003) Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. Mol. Cell. Biol., 23, 206-215.
34. Aplin,A.E. et al. (1998) Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol. Rev., 50, 197-263.
35. Trosko,J.E. (2003) The role of stem cells and gap junctional intercellular communication in carcinogenesis. J. Biochem. Mol. Biol., 36, 43-48.
36. Yeaman,C. et al. (1999) New perspectives on mechanisms involved in generating epithelial cell polarity. Physiol. Rev., 79, 73-98.
37. Reddig,P.J. et al. (2005) Clinging to life: cell to matrix adhesion and cell survival. Cancer Metastasis Rev., 24, 425-439.
38. Aberle,H. et al. (1996) Cadherin-catenin complex: protein interactions and their implications for cadherin function. J. Cell. Biochem., 61, 514-523.
39. Hirohashi,S. et al. (2003) Cell adhesion system and human cancer morphogenesis. Cancer Sci., 94, 575-581.
40. Nose,A. et al. (1988) Expressed recombinant cadherins mediate cell sorting in model systems. Cell, 54, 993-1001.
41. Chrenek,M.A. et al. (2001) Tumour-stromal interactions. Integrins and cell adhesions as modulators of mammary cell survival and transformation. Breast Cancer Res., 3, 224-229.
42. Hsu,M.Y. et al. (2000) E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am. J. Pathol., 156, 1515-1525.
43. Haass,N.K. et al. (2005) Adhesion, migration and communication in melanocytes and melanoma. Pigment Cell Res., 18, 150-159.
44. Vleminckx,K. et al. (1991) Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 66, 107-119.
45. Kanai,Y. et al. (1997) The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int. J. Cancer, 71, 355-359.
46. Matsumura,T. et al. (2001) Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas. Clin. Cancer Res., 7, 594-599.
47. Weaver,V.M. et al. (1996) The importance of the microenvironment in breast cancer progression: recapitulation of mammary tumorigenesis using a unique human mammary epithelial cell model and a three-dimensional culture assay. Biochem. Cell Biol., 74, 833-851.
48. Hoover,K.B. et al. (1998) Loss of the tight junction MAGUK ZO-1 in breast cancer: relationship to glandular differentiation and loss of heterozygosity. Am. J. Pathol., 153, 1767-1773.
49. Glukhova,M. et al. (1995) Adhesion systems in normal breast and in invasive breast carcinoma. Am. J. Pathol., 146, 706-716.
50. Bates,R.C. et al. (1994) Apoptosis induced by inhibition of intercellular contact. J. Cell. Biol., 125, 403-415.
51. Kerbel,R.S. et al. (1996) Induction and reversal of cell adhesion-dependent multicellular drug resistance in solid breast tumors. Hum. Cell., 9, 257-264.
52. Thiery,J.P. (2002) Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer, 2, 442-454.
53. Howlett,A.R. et al. (1995) Cellular growth and survival are mediated by beta 1 integrins in normal human breast epithelium but not in breast carcinoma. J. Cell. Sci., 108, 1945-1957.
54. Weaver,V.M. et al. (1999) Functional culture models to study mechanisms governing apoptosis in normal and malignant mammary epithelial cells. J. Mammary Gland Biol. Neoplasia, 4, 193-201.
55. Weaver,V.M. et al. (1997) Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell. Biol., 137, 231-245.
56. Degen,W.G. et al. (1998) MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule). Am. J. Pathol., 152, 805-813.
57. Holzmann,B. et al. (1998) Alpha 4 integrins and tumor metastasis. Curr. Top. Microbiol. Immunol., 231, 125-141.
58. Paietta,E. et al. (1998) Acute myeloid leukaemia expressing the leucocyte integrin CD11b-a new leukaemic syndrome with poor prognosis: result of an ECOG database analysis. Eastern Cooperative Oncology Group. Br. J. Haematol., 100, 265-272.
59. Lapidot,T. et al. (2005) How do stem cells find their way home? Blood, 106, 1901-1910.
60. Wilson,A. et al. (2006) Bone-marrow haematopoietic-stem-cell niches. Nat. Rev. Immunol., 6, 93-106.
61. Matsunaga,T. et al. (2003) Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nat. Med., 9, 1158-1165.
62. Jones,P.A. et al. (2007) The epigenomics of cancer. Cell, 128, 683-692.
63. Christofori,G. et al. (1999) The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem. Sci., 24, 73-76.
64. Hirohashi,S. (1998) Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am. J. Pathol., 153, 333-339.
65. Strathdee,G. (2002) Epigenetic versus genetic alterations in the inactivation of E-cadherin. Semin. Cancer Biol., 12, 373-379.
66. Tamura,G. et al. (2001) Molecular characterization of undifferentiated-type gastric carcinoma. Lab. Invest., 81, 593-598.
67. Tamura,G. et al. (2000) E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J. Natl Cancer Inst., 92, 569-573.
68. Wheeler,J.M. et al. (2001) Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer. Gut, 48, 367-371.
69. Corn,P.G. et al. (2000) E-cadherin expression is silenced by 5′ CpG island methylation in acute leukemia. Clin. Cancer Res., 6, 4243-4248.
70. Melki,J.R. et al. (2000) Hypermethylation of E-cadherin in leukemia. Blood, 95, 3208-3213.
71. Batlle,E. et al. (2000) The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol., 2, 84-89.
72. Cano,A. et al. (2000) The transcription factor snail controls epithelialmesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol., 2, 76-83.
73. Aigner,K. et al. (2007) The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene, 26, 6979-6988.
74. Burk,U. et al. (2008) A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep., 9, 582-589.
75. Mahlknecht,U. et al. (2008) Histone deacetylase inhibitor treatment downregulates VLA-4 adhesion in hematopoietic stem cells and acute myeloid leukemia blast cells. Haematologica, 93, 443-446.
76. Maeda,T. et al. (2000) Up-regulation of costimulatory/adhesion molecules by histone deacetylase inhibitors in acute myeloid leukemia cells. Blood, 96, 3847-3856.
77. Bringuier,P.P. et al. (1993) Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res., 53, 3241-3245.
78. Heino,J. (1996) Biology of tumor cell invasion: interplay of cell adhesion and matrix degradation. Int. J. Cancer, 65, 717-722.
79. Lane,A.A. et al. (2009) Histone deacetylase inhibitors in cancer therapy. J. Clin. Oncol., 27, 5459-5468.